Waters Corporation has established a team in the AstraZeneca BioVentureHub in Gothenburg, Sweden.
By locating in the AstraZeneca BioVentureHub, the dedicated team of 7-10 Waters analytical technology specialists will interact closely with AstraZeneca scientists to catalyze innovation opportunities in analytical science, the company states.
“This is a fantastic opportunity for us to work side-by-side with exceptional, world-leading, AstraZeneca scientists. We know they will stretch our thinking and inspire our innovations. We will get a much better understanding of how our analytical technologies and solutions are used, and how they can be improved to ultimately deliver benefit that can help enhance human health and well-being,” says Christina Turner, General Manager for Northern Europe at Waters.
Innovative analytical systems and workflows
Waters and AstraZeneca already have a close collaboration when it comes to specialty measurement tools and technologies. The co-location at the R&D Gothenburg site, brings together Waters and AstraZeneca scientists in analytical science, software development and systems integration.
Being based in the BioVentureHub will help to promote collaborative effectiveness and shared best practices that will influence the joint development of next generation instrumentation and data analysis tools, states Waters.
“At AstraZeneca, we are continuously building and investing in scientific capabilities and technologies with the aim of advancing science and achieving the next wave of breakthroughs. Having Waters’ know-how and expertise close at hand in the BioVentureHub will help us accelerate the design and delivery of innovative analytical systems and workflows,” says Anders Holmén, Vice President and Head of Pharmaceutical Sciences, R&D, AstraZeneca.